Examiner: SHIBUYA, MARK LANCE

Tech Center 1600 • Art Units: 1624 1631 1641 1677 1678

This examiner grants 32% of resolved cases

Performance Statistics

32.3%

Allow Rate

-27.7% vs TC avg

187

Total Applications

+24.9%

Interview Lift

1341

Avg Prosecution Days

Based on 158 resolved cases, 2023–2026

4.1%

§101 Eligibility

18.4%

§102 Novelty

38.4%

§103 Obviousness

27.6%

§112 Clarity

App #	Title	Status	Assignee
17919052	ENHANCED EFFECTS OF GENE-IMMUNOTHERAPY AND IMMUNOSUPPRESSANTS IN MULTIPLE SCLEROSIS	Non-Final OA	University of Florida Research Foundation, Incorporated
16487517	METHODS OF PHOTOCHEMICAL TREATMENT FOR WOUND HEALING	Non-Final OA	The General Hospital Corporation
17870607	RIBOSOME TERMINATION STRUCTURES AND USE THEREOF	Non-Final OA	RAMOT AT TEL-AVIV UNIVERSITY LTD

IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.